Choline kinase α interacts with epidermal growth factor receptor to activate the mitogen-activated protein kinase pathway and contributes to glioma tumorigenesis
8
作者人数
0
被引次数
来源:Crossref,截至 2026-10-20
作者
- 1 Yourui Zou 第一作者
- 2 Xiao Wu
- 3 Yang Liu
- 4 Yang Zhao
- 5 Haibo Liu
- 6 Jin Feng
- 7 Peng Gao
- 8 Hui Ma
参考文献 共 41 条
- 1 Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- 2 Cancer statistics, 2023
- 3 Management of glioblastoma: State of the art and future directions
- 4 Primary brain tumours in adults 10.1016/s0140-6736(23)01054-1
- 5 Diffuse glioma heterogeneity and its therapeutic implications 10.1158/2159-8290.cd-20-1474
- 6 Glioma diagnosis and therapy: Current challenges and nanomaterial-based solutions 10.1016/j.jconrel.2022.09.065
- 7 Immunotherapy for malignant glioma: Current status and future directions 10.1016/j.tips.2019.12.003
- 8 Molecular structure and differential function of choline kinases CHKα and CHKβ in musculoskeletal system and cancer 10.1016/j.cytogfr.2016.10.002
- 9 Choline kinases: Enzymatic activity, involvement in cancer and other diseases, inhibitors 10.1002/ijc.35286
- 10 Exploiting altered patterns of choline kinase-alpha expression on human prostate tissue to prognosticate prostate cancer 10.1136/jclinpath-2015-202859
- 11 Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: A retrospective study 10.1016/s1470-2045(07)70279-6
- 12 Choline kinase alpha and hexokinase-2 protein expression in hepatocellular carcinoma: Association with survival 10.1371/journal.pone.0046591
- 13 Choline kinase alpha 2 acts as a protein kinase to promote lipolysis of lipid droplets 10.1016/j.molcel.2021.05.005
- 14 Recent advances in the design of choline kinase α inhibitors and the molecular basis of their inhibition 10.1002/med.21746
- 15 Small molecule EGFR inhibitors as anti-cancer agents: Discovery, mechanisms of action, and opportunities 10.3390/ijms24032651
- 16 EGFR in cancer: Signaling mechanisms, drugs, and acquired resistance 10.3390/cancers13112748
- 17 MAPK signaling pathway-based glioma subtypes, machine-learning risk model, and key hub proteins identification 10.1038/s41598-023-45774-0
- 18 The functional role of p38 MAPK pathway in malignant brain tumors 10.3389/fphar.2022.975197
- 19 Chinese glioma genome atlas (CGGA): A comprehensive resource with functional genomic data from chinese glioma patients 10.1016/j.gpb.2020.10.005
- 20 UALCAN: An update to the integrated cancer data analysis platform 10.1016/j.neo.2022.01.001
- 21 Choline kinase alpha as an androgen receptor chaperone and prostate cancer therapeutic target 10.1093/jnci/djv371
- 22 Choline kinase alpha regulates autophagy-associated exosome release to promote glioma cell progression 10.1016/j.bbrc.2024.151269
- 23 Knockdown of choline kinase α (CHKA) inhibits the proliferation, invasion and migration of human U87MG glioma cells (in Chinese)
- 24 In vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cells 10.1371/journal.pone.0180263
- 25 Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells 10.18632/oncotarget.12337
- 26 Can EGFR be a therapeutic target in breast cancer 10.1016/j.bbcan.2022.188789
- 27 Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways 10.1186/s12943-017-0621-z
- 28 Dual EGFR-VEGF pathway inhibition: A promising strategy for patients with EGFR-mutant NSCLC 10.1016/j.jtho.2020.10.006
- 29 An anti-EGFR antibody-drug radioconjugate labeled with actinium-225 elicits durable antitumor responses in KRAS- and BRAF-mutant colorectal cancer 10.1158/0008-5472.can-24-2266
- 30 DRD1 suppresses cell proliferation and reduces EGFR activation and PD-L1 expression in NSCLC 10.1002/1878-0261.13608
- 31 Prognostic and predictive biomarkers in gliomas 10.3390/ijms221910373
- 32 IGF2BP3-EGFR-AKT axis promotes breast cancer MDA-MB-231 cell growth 10.1016/j.bbamcr.2023.119542
- 33 VPS35 promotes cell proliferation via EGFR recycling and enhances EGFR inhibitors response in gastric cancer 10.1016/j.ebiom.2023.104451
- 34 MicroRNA-137 regulates hypoxia-mediated migration and epithelial-mesenchymal transition in prostate cancer by targeting LGR4 via the EGFR/ERK signaling pathway 10.3892/ijo.2020.5064
- 35 Updated insights on EGFR signaling pathways in glioma 10.3390/ijms22020587
- 36 Functional interactions between Choline kinase α, epidermal growth factor receptor and c-Src in breast cancer cell proliferation 10.1038/onc.2011.332
- 37 A functional siRNA screen identifies genes modulating angiotensin II-mediated EGFR transactivation
- 38 Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma 10.18632/oncotarget.11433
- 39 Choline kinase α mediates interactions between the epidermal growth factor receptor and mechanistic target of rapamycin complex 2 in hepatocellular carcinoma cells to promote drug resistance and xenograft tumor progression 10.1053/j.gastro.2016.12.033
- 40 A novel small molecule antagonist of choline kinase-α that simultaneously suppresses MAPK and PI3K/AKT signaling 10.1038/onc.2011.51
- 41 Choline kinase alpha promoted glioma development by activating PI3K/AKT signaling pathway
数据来源
- 论文信息:
- 中华医学期刊网、Crossref
- 作者名单:
- Crossref
- 被引次数:
- Crossref,截至 2026-10-20
- 参考文献:
- Crossref
论文的著作权归作者与出版方所有,本站只整理公开的题录信息并附原文链接,不构成任何医疗建议。